Authors


Kylie Price, PharmD

Latest:

June 2023 Interactive Case Studies

Cases highlight patients who have attention-deficity/hyperactivity disorder and diabetic peripheral nephropathy.


Jason Ausili, Chief Clinical Officer, FDS Amplicare

Latest:

Community Pharmacies Positioned to be the Epicenter of Care

Community pharmacists have an essential role to play during this phase of the crisis that could further entrench them as the epicenter of care in the communities they serve.


Shelby Quinn, PharmD, BCOP

Latest:

More Options, More Questions: How Pharmacists Are Managing EGFR-Positive Non-Small Cell Lung Cancer

Shelby Quinn, PharmD, BCOP shares insights about treatment using osimertinib in early lines.


Brenda Shafer

Latest:

A 340B Compromise at Last? Draft Federal Legislation May Provide a Clear Path Forward

In an ambitious effort to address the ongoing uncertainty within the 340B Program space, 6 senators released a draft discussion bill earlier this year titled the SUSTAIN Act.


Megan Menon, PharmD, BCOP

Latest:

Antineoplastic Extravasation Prevention, Management

Extravasation is defined as the inadvertent leakage of a vesicant from the vein into the surrounding tissue.


Peter Gordinier

Latest:

A Pharmacist’s Guide to Medical Cannabis Interactions and Patient Care

As access becomes easier, pharmacists are more likely to encounter questions.


Steffanie Ung, PharmD Candidate

Latest:

Clinical Overview: Teprotumumab for Thyroid Eye Disease

Teprotumumab is the first fully human IgG1 monoclonal antibody approved by the FDA for the treatment of thyroid eye disease at its source not just reducing the symptoms.


Harsha Rajasimha, PhD

Latest:

Fostering Equity in Health Care Research: Eliminating Gender Bias With Decentralized Clinical Trials for Women

Decentralized clinical trials are emerging as a method by which to address gender bias in clinical research.


Delaney Savage, PharmD

Latest:

Pharmacists Have a Significant Role in Chronic Kidney Disease

The Kidney Disease: Improving Global Outcomes guidelines can provide pharmacists with approaches to minimizing chronic kidney disease progression and complications.


Jason Borschow

Latest:

2030: The Beginning of a New Era in Health Care

By setting a standard for prescriptions that improves member access, outcomes, and experience, we will establish a path forward for every facet of health care.


James Wallace, MBA, DBA

Latest:

Case Studies in Pharmacogenomics

The potential to optimize medication efficacy and safety across diverse populations is garnering attention in various health care settings.


Sarah Nelson, PharmD

Latest:

Medication Compliance When Treating CKD is Crucial, UPMC Health Plan Expert Says

Helping patients adhere to their medications to manage their chronic kidney disease (CKD) and comorbidities is one of the key areas pharmacists should prioritize.


Erin Lexner, PharmD, BCPS

Latest:

From Inpatient to Outpatient: A Pharmacy-Led Evolution in Transplant Care

Erin Lexner, PharmD, BCPS, discussed her team’s experience transitioning to outpatient BEAM from inpatient CBV.


John Ahler, RPh

Latest:

Locking Prescription Vials Helps Keep Medicine Safe in Medication-assisted Treatment Programs

For patients with opioid use disorder, medication-assisted treatment programs are a clinically effective approach.


Colleen McCabe, PharmD, BCOP

Latest:

Removing Mesna From Cyclophosphamide Cycles in VAdriaC-IE for Ewing Sarcoma

This retrospective cohort study provides preliminary evidence for safe removal of mesna from VAdriaC cycles, as the incidence of hemorrhagic cystitis did not increase in patients with Ewing sarcoma who received cyclophosphamide without prophylactic mesna.


Chris Peshek, PharmD, RPh

Latest:

The Power of Our Voice: Why Pharmacists Must Advocate for Our Profession

Advocacy ensures that policymakers understand the realities on the ground. If we fail to speak up, decisions about our profession will be made without our input—often by individuals who lack the expertise and perspective we bring to the table.


Cara Chang, PharmD, BCOP

Latest:

First-Line Focus: Molecular Testing and Guideline-Directed Therapy in EGFR-Positive NSCLC

A panelist discusses how waiting for molecular testing results before initiating treatment for non–small cell lung cancer (NSCLC) is crucial because patients with EGFR mutations can avoid chemotherapy and immunotherapy in favor of targeted oral agents like osimertinib, which offer survival benefits with minimal toxicity compared to traditional treatments, while premature immunotherapy could cause severe immune-related adverse events that might preclude later use of more appropriate targeted therapies.


Jessie Lee, PharmD

Latest:

Pharmacists Have a Significant Role in Chronic Kidney Disease

The Kidney Disease: Improving Global Outcomes guidelines can provide pharmacists with approaches to minimizing chronic kidney disease progression and complications.


Kwang Yoon, PharmD, BCPS, BCEMP

Latest:

Paradoxical Hypotension After Inadvertent Intravenous Administration of Epinephrine

Raising awareness of the potentially fatal cardiovascular complications of epinephrine toxicity.


Carmen Witsken, PharmD

Latest:

Is It Too Late to Get a Flu Shot?

Ideally, older patients receive vaccinations by October, but disease activity often peaks in February or March.


Ron Welch, PharmD, BCPS, BCIDP

Latest:

Pharmacists’ Role in Antibiotic Stewardship: Understanding Spectrums to Combat Resistance

Pharmacists ensure responsible antibiotic use, combating resistance through tailored therapies.


Chris Stidman

Latest:

As Part of the Clinical Care Team, Pharmacists Can Enable Greater Medication Access, Boost Adherence, and Improve Health Outcomes

Pharmacists today are an integral part of a patient’s care journey, providing clinical expertise and support that improves medication adherence, increases access to medication and advances health outcomes.


Nicholas Kolano, PharmD candidate

Latest:

FDA Is Evaluating the Prospect of Removing Phenylephrine From OTC Shelves

Oral phenylephrine is a common ingredient in OTC products, but its clinical efficacy is questionable. The FDA is considering removing it from the market.


Sean Marchese, MS, RN

Latest:

Effort Is Needed to Address Climate Change-Associated Cancer Risk in the United States

The data show that the 10-year survival rate of patients with breast cancer who survived Hurricane Katrina was much lower than those who did not face a major weather event.


Thomas Dobmeyer, MD

Latest:

Access to Medicine, Clinical Trials Jeopardized by Ukraine War

There are a huge number of medical facilities in Ukraine that run international clinical trials, with the FDA noting that more than 250 drugs and devices were undergoing clinical research in Ukraine.


Alexander Maciejewski, PharmD, MSLD, AAHIVP

Latest:

Community Pharmacists and Technicians: Impacting Public Health One Service at a Time

Community-based pharmacy services are reaching new heights as pharmacists and pharmacy technicians are able to have a larger impact on patient care than ever before.


Jena Quinn, PharmD, BCPPS

Latest:

Pediatric Weight is Crucial to Perfecting the Dose

Evidence indicates that up to 25% of all prescriptions for children could be dosed inappropriately, making it the most common type of medication administration error.


Jessica Huston, PharmD

Latest:

Focus on Human Papillomavirus Virus Vaccination in Adults and Young Adults

Combining strong evidence-based recommendations with caring, compassionate, and frequent counseling opportunities hopefully will increase vaccine acceptance and ultimately reduce the incidence of HPV and associated cancers among our patients.


Brittany Riley, PharmD, BCPS, MS

Latest:

Gabapentin Presents High Potential for Misuse

Although the anticonvulsant is not considered a controlled substance, some state legislation focuses on monitoring the use of or reclassifying it.


Ashly McPhillips, PharmD

Latest:

Protecting Against Shingles: Discussing With Your Patients Why Vaccination Matters

Trisha Winroth, PharmD, and Ashly McPhillips, PharmD, discuss how the shingles vaccine works to prevent reactivation of the varicella-zoster virus and reduce shingles risk, and how to effectively address patient concerns and misconceptions about the vaccine’s benefits, symptoms, and complications of shingles.